Beijing Friendship Hospital: clinical-trial pipeline
Beijing Friendship Hospital is the sponsor of 217 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 76 are not yet finished and 4 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 155 |
| Phase 2 | 19 |
| Phase 3 | 15 |
| Phase 4 | 11 |
| Phase 2/3 | 7 |
| Phase 1 | 5 |
| Phase 1/2 | 3 |
| Early phase 1 | 2 |
Trials by status
| Status | Trials |
|---|---|
| Unknown | 106 |
| Recruiting | 48 |
| Completed | 35 |
| Not yet recruiting | 23 |
| Active, not recruiting | 5 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 57 |
| Gastroenterology and liver | 50 |
| Infectious disease and vaccines | 36 |
| Cardiovascular | 24 |
| Metabolic and endocrine (diabetes, obesity) | 23 |
| Nephrology and urology | 11 |
| Rare and genetic diseases | 11 |
| Neurology | 7 |
| Immunology and rheumatology | 6 |
| Musculoskeletal | 2 |
| Ophthalmology | 2 |
| Psychiatry and mental health | 2 |
Countries
| Country | Trials |
|---|---|
| China | 194 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-09-22 | New trial posted | Image-Guided Platform-Assisted Sentinel Lymph Node Retrieval in Early Gastric Cancer |
| 2026-09-17 | New trial posted | Disposable Intestinal Isolation and Protection Device for Patients With Rectal and Lower… |
| 2026-09-16 | New trial posted | DeepMedFake-Assisted Detection of Synthetic and Discordant Medical Images |
| 2026-08-31 | New trial posted | Validating a Medical AI Fine-Tuning Platform for Major Diseases |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT06855758 | Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation | Not applicable | Active, not recruiting | China |
| NCT05434026 | Chinese Colorectal Cancer Database | Not applicable | Recruiting | China |
| NCT07393048 | Application and Exploration of Personalized ctDNA-MRD Detection Technology in Predicting the Efficacy of Neoa… | Not applicable | Recruiting | China |
| NCT03520699 | Beijing Friendship Hospital Metabolic Surgery Database | Not applicable | Recruiting | China |
| NCT07312864 | Safety and Tolerability Study of a Novel Bioartificial Liver in Liver Failure and Small-for-Size Syndrome | Phase 1/2 | Recruiting | China |
| NCT06364462 | Precise Evaluation Criteria for Histological Regression of NASH Fibrosis | Not applicable | Not yet recruiting | |
| NCT07353684 | Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer | Phase 2 | Recruiting | China |
| NCT06056804 | Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-… | Phase 2 | Active, not recruiting | China |
| NCT07369739 | Golidocitinib Combined With Selinexor for CAEBVD | Phase 2/3 | Recruiting | China |
| NCT03777969 | Prediction System of Clinical Endpoint Events for Chronic Hepatitis B Patients | Not applicable | Active, not recruiting | China |
| NCT05546086 | BeijngFH Health Cohort Study | Not applicable | Recruiting | China |
| NCT07135141 | Mazdutide as Adjuvant Therapy Following Sleeve Gastrectomy in Severe Obesity | Not applicable | Not yet recruiting | China |
| NCT05015283 | Efficacy and Safety of One-anastomosis Versus Roux-en-Y Gastric Bypass for Type 2 Diabetes Remission | Not applicable | Recruiting | China |
| NCT07725874 | Safety and Efficacy of Liposomal Amphotericin B for Patients With Invasive Mold Diseases in Liver Transplant… | Not applicable | Not yet recruiting | |
| NCT05539781 | Change of Hemodynamics and Cerebral Functions After Carotid Artery Revascularization | Not applicable | Recruiting | China |
| NCT06356506 | A Study on Factors of Biochemical Response in Autoimmune Hepatitis | Not applicable | Not yet recruiting | China |
| NCT05245474 | Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer | Phase 2 | Recruiting | China |
| NCT04366999 | Effectiveness of Bariatric Surgery for NAFLD/NASH | Not applicable | Recruiting | China |
| NCT06773221 | The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis | Not applicable | Not yet recruiting | China |
| NCT06710574 | Multimodal Image Technologies Investigate the Role and Mechanism of Probiotics in Improving RBD with Parkinso… | Phase 4 | Recruiting | China |
| NCT05962892 | A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma | Not applicable | Recruiting | China |
| NCT07566559 | Rectal Cancer Neoadjuvant Therapy-Real World Study | Not applicable | Recruiting | China |
| NCT03800160 | Greater China Metabolic and Bariatric Surgery Database | Not applicable | Recruiting | China |
| NCT03131427 | China Registry for Genetic / Metabolic Liver Diseases | Not applicable | Recruiting | China |
| NCT07315854 | Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metasta… | Phase 2 | Recruiting | China |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Beijing Friendship Hospital clinical trials: 76 open, 22 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/beijing-friendship-hospital/, data as of 2026-10-25.